News Daily News Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years Yael L. Maxwell June 09, 2025
News Daily News New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again Yael L. Maxwell November 27, 2024
News Daily News Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift Yael L. Maxwell May 03, 2024
News Daily News Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2 Michael O'Riordan January 03, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2023 Shelley Wood November 01, 2023
News Daily News Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis Yael L. Maxwell September 05, 2023
News Conference News SCAI 2023 Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis L.A. McKeown May 22, 2023
News Daily News A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4 Shelley Wood April 14, 2023
News Daily News Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention Michael O'Riordan March 30, 2022
News Daily News Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients Shelley Wood December 22, 2021
News Daily News Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All L.A. McKeown April 05, 2021
News Daily News Site Investigators Missed Clinical Events in GLOBAL LEADERS Michael O'Riordan February 12, 2021
News Daily News ‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests Michael O'Riordan September 18, 2020
News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020